444 results
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
health professionals (HPs)
I/C
formal R/S-training, physicians, nurses
O
belief in influence of R/S on patients' health, prevalence of formal R/S-training
P
patients with cancer
I/C
religion and spirituality (R&S), no specific comparison group
O
patient outcomes in cancer care
P
patients with coronary artery disease (CAD)
I/C
robotically assisted PCI (R-PCI), standard PCI (S-PCI)
O
clinical success, procedure time, fluoroscopy time, contrast use, radiation exposure
P
GNB suspected for carbapenemase production
I/C
Xpert Carba-R assay, Other methods of detecting carbapenemase genes in GNB
O
Accuracy of Xpert Carba-R assay in detecting carbapenemase genes in GNB
P
Evolut R/Pro, Sapien 3
I/C
transcatheter aortic valve implantation (TAVI), Evolut R/Pro vs Sapien 3
O
all-cause mortality (short and long-term), stroke, bleeding, permanent pacemaker implantation (PPI), acute kidney injury (AKI), major vascular complication, device success, moderate-severe aortic regurgitation (AR), pressure gradients
P
HBV+ donors, HBV+ recipients
I/C
D+/R- heart transplantation, D-/R+ heart transplantation
O
fewer active hepatitis infections, lower hepatitis-related mortality, comparable survival at 1 y
P
OCD patients
I/C
r-TMS, SSRI
O
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) scores
P
metastatic or recurrent gastric cancer patients
I/C
capecitabine-based chemotherapy, S-1-based chemotherapy
O
objective response rate, 6-, 12-, and 18-month progression-free survival, 1-, 2-, and 3-year overall survival, adverse events (hand-foot syndrome, neutropenia)
P
GSNO
I/C
S-Nitrosoglutathione, Placebo
O
Infarct size, Neurological behavior scales, Embolic signals